Sglt 2 Inhibitors | List of Frontiers open access articles

Review

Published on 28 Feb 2022

Emerging Roles of Sodium Glucose Cotransporter 2 (SGLT-2) Inhibitors in Diabetic Cardiovascular Diseases: Focusing on Immunity, Inflammation and Metabolism

in Cardiovascular and Smooth Muscle Pharmacology

Lingxiang Xie
Yang Xiao
Shi Tai
Huijie Yang
Shenghua Zhou
Zhiguang Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2022.836849

7,279 views
30 citations

Review

Published on 21 Sep 2023

Role and mechanisms of SGLT-2 inhibitors in the treatment of diabetic kidney disease

in Inflammation

Zhi-Cheng Dai
Jin-Xia Chen
Rong Zou
Xuan-Bing Liang
Ji-Xin Tang
Cui-Wei Yao

Frontiers in Immunology

doi 10.3389/fimmu.2023.1213473

25,821 views
51 citations

Systematic Review

Published on 21 Oct 2021

Adding Sodium–Glucose Co-Transporter 2 Inhibitors to Sulfonylureas and Risk of Hypoglycemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

in Clinical Diabetes

Meng Jiang
Qiaoshu Liu
Tiejian Jiang
Paul Nizigiyimana
Minxiang Lei

Frontiers in Endocrinology

doi 10.3389/fendo.2021.713192

8,902 views
4 citations

Original Research

Published on 05 Aug 2024

Retrospective analysis of the effect of SGLT-2 inhibitors on renal function in patients with type 2 diabetes in the real world

in Drugs Outcomes Research and Policies

Rongjing Song
Qiaoyu Hou
Xiuying Zhang
Wei Zhao
Gang Liu
Meng Li
Xiaohong Zhang
Linong Ji

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1376850

3,488 views
4 citations

Review

Published on 13 Nov 2018

The Intersection of Diabetes and Cardiovascular Disease—A Focus on New Therapies

in Cardiovascular Epidemiology and Prevention

Devinder S. Dhindsa
Pratik B. Sandesara
Michael D. Shapiro

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2018.00160

5,763 views
6 citations

Original Research

Published on 12 Apr 2024

Case literature analysis of Fournier’s gangrene caused by sodium-glucose protein-2 inhibitors

in Infectious Diseases: Pathogenesis and Therapy

Hailing Liu

Frontiers in Medicine

doi 10.3389/fmed.2024.1301105

5,125 views
8 citations

Systematic Review

Published on 28 Aug 2023

Comparative safety of different sodium-glucose transporter 2 inhibitors in patients with type 2 diabetes: a systematic review and network meta-analysis of randomized controlled trials

in Clinical Diabetes

Chun Xing Li
Li Yan Liu
Chen Xiao Zhang
Xu Hua Geng
Si Meng Gu
Yu Qiao Wang
Hua Liu
Qing Xie
Shuo Liang

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1238399

17,895 views
29 citations

Review

Published on 01 Jul 2025

Application of SGLT-2 inhibitors in non-diabetic CKD: mechanisms, efficacy, and safety

in Nephrology

Bing Zhang
Liufei Deng

Frontiers in Medicine

doi 10.3389/fmed.2025.1574693

8,716 views
8 citations

Review

Published on 07 Dec 2021

Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Concurrent Type 2 Diabetes Mellitus and Non-Alcoholic Steatohepatitis: A Review of the Evidence

in Clinical Diabetes

Koichi Yabiku

Frontiers in Endocrinology

doi 10.3389/fendo.2021.768850

9,243 views
25 citations

Original Research

Published on 15 Jan 2025

A study on the pharmacovigilance of various SGLT-2 inhibitors

in Precision Medicine

Yanwen Dong
Yangyang Wang
Xiaomei Lan
Huiyan Zeng

Frontiers in Medicine

doi 10.3389/fmed.2024.1515847

4,149 views
3 citations

Systematic Review

Published on 10 Jan 2023

The effect of SGLT-2 inhibitors on cardiorespiratory fitness capacity: A systematic review and meta-analysis

in Exercise Physiology

Yong Peng
Di Qin
Yudi Wang
Lian Xue
YaXuan Qin
Xin Xu

Frontiers in Physiology

doi 10.3389/fphys.2022.1081920

7,090 views
15 citations

Original Research

Published on 28 Nov 2022

Quantitative effects of sodium–glucose cotransporter-2 inhibitors dapagliflozin and empagliflozin on quality of life in heart failure patients

in Cardiovascular and Smooth Muscle Pharmacology

Dong-Dong Wang
Cun Zhang
Ping Zhu
Su-Mei He
Xiao Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2022.910858

2,785 views

Systematic Review

Published on 25 Oct 2021

Patients With Type 2 Diabetes Mellitus and Heart Failure Benefit More From Sodium-Glucose Cotransporter 2 Inhibitor: A Systematic Review and Meta-Analysis

in Clinical Diabetes

Chengcong Chen
Hong Peng
Mingzhu Li
Xiyan Lu
Miao Huang
Yongmei Zeng
Guoqing Dong

Frontiers in Endocrinology

doi 10.3389/fendo.2021.664533

6,226 views
10 citations

Review

Published on 20 Mar 2025

Emerging horizons: clinical applications and multifaceted benefits of SGLT-2 inhibitors beyond diabetes

in Clinical and Translational Cardiovascular Medicine

Qing Feng
Miaoqiong Wu
Zizhao Mai

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1482918

6,375 views
6 citations

Case Report

Published on 01 Dec 2023

Successful treatment of nivolumab and ipilimumab triggered type 1 diabetes by using sodium-glucose transporter 2 inhibitor: a case report and systematic review

in Clinical Diabetes

Makoto Fujiwara
Masaru Shimizu
Tatsuya Okano
Yuko Maejima
Kenju Shimomura

Frontiers in Public Health

doi 10.3389/fpubh.2023.1264056

5,321 views
4 citations

Systematic Review

Published on 23 Oct 2025

GLP1 receptor agonists and SGLT2 inhibitors for the prevention or delay of type 2 diabetes mellitus onset: a systematic review and meta-analysis

in Clinical Diabetes

Farah Ghobar
Ali Tarhini
Zeinab Osman
Sergio Sbeih
Ralph Abou Ghayda
Patena Matar
Gaelle Haddad
Amjad Kanaan
Assaad Eid
Sami Azar

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1627909

4,249 views
2 citations

Articles

Emerging Roles of Sodium Glucose Cotransporter 2 (SGLT-2) Inhibitors in Diabetic Cardiovascular Diseases: Focusing on Immunity, Inflammation and Metabolism

Role and mechanisms of SGLT-2 inhibitors in the treatment of diabetic kidney disease

Adding Sodium–Glucose Co-Transporter 2 Inhibitors to Sulfonylureas and Risk of Hypoglycemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Retrospective analysis of the effect of SGLT-2 inhibitors on renal function in patients with type 2 diabetes in the real world

The Intersection of Diabetes and Cardiovascular Disease—A Focus on New Therapies

Case literature analysis of Fournier’s gangrene caused by sodium-glucose protein-2 inhibitors

Comparative safety of different sodium-glucose transporter 2 inhibitors in patients with type 2 diabetes: a systematic review and network meta-analysis of randomized controlled trials

Application of SGLT-2 inhibitors in non-diabetic CKD: mechanisms, efficacy, and safety

Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Concurrent Type 2 Diabetes Mellitus and Non-Alcoholic Steatohepatitis: A Review of the Evidence

A study on the pharmacovigilance of various SGLT-2 inhibitors

The effect of SGLT-2 inhibitors on cardiorespiratory fitness capacity: A systematic review and meta-analysis

Quantitative effects of sodium–glucose cotransporter-2 inhibitors dapagliflozin and empagliflozin on quality of life in heart failure patients

Patients With Type 2 Diabetes Mellitus and Heart Failure Benefit More From Sodium-Glucose Cotransporter 2 Inhibitor: A Systematic Review and Meta-Analysis

Emerging horizons: clinical applications and multifaceted benefits of SGLT-2 inhibitors beyond diabetes

Successful treatment of nivolumab and ipilimumab triggered type 1 diabetes by using sodium-glucose transporter 2 inhibitor: a case report and systematic review

GLP1 receptor agonists and SGLT2 inhibitors for the prevention or delay of type 2 diabetes mellitus onset: a systematic review and meta-analysis